RIGL
Rigel Pharmaceuticals, Inc.
NASDAQ · Healthcare · Biotechnology · US
$48.67
+0.35%Margins
Gross margin
91.4%
EBITDA margin
34.0%
EBIT margin
31.5%
Net margin
116.3%
FCF margin
28.7%
75.7%
Return on equity
61.8%
Return on assets
18.7%
Return on invested capital
0.54x
Asset turnover
$79.4M
Cash from operations
$5.10
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026